SG10201810450QA - Organoarsenic compounds and methods for the treatment of cancer - Google Patents
Organoarsenic compounds and methods for the treatment of cancerInfo
- Publication number
- SG10201810450QA SG10201810450QA SG10201810450QA SG10201810450QA SG10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- treatment
- methods
- organoarsenic compounds
- organoarsenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18951108P | 2008-08-20 | 2008-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201810450QA true SG10201810450QA (en) | 2018-12-28 |
Family
ID=41707414
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201810449XA SG10201810449XA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201403869TA SG10201403869TA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201810450QA SG10201810450QA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201810449XA SG10201810449XA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201403869TA SG10201403869TA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20110269697A1 (zh) |
| EP (2) | EP2321012B1 (zh) |
| JP (5) | JP5933896B2 (zh) |
| KR (3) | KR20180103194A (zh) |
| CN (2) | CN102149432A (zh) |
| AU (1) | AU2009282972A1 (zh) |
| BR (1) | BRPI0918407A2 (zh) |
| CA (1) | CA2734650A1 (zh) |
| DK (2) | DK2321012T3 (zh) |
| ES (2) | ES2703740T3 (zh) |
| HK (2) | HK1254607A1 (zh) |
| IL (1) | IL211153A0 (zh) |
| MX (1) | MX2011001800A (zh) |
| NZ (1) | NZ591181A (zh) |
| PT (2) | PT2321012T (zh) |
| RU (1) | RU2534606C2 (zh) |
| SG (3) | SG10201810449XA (zh) |
| WO (1) | WO2010021928A1 (zh) |
| ZA (1) | ZA201101216B (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160304546A1 (en) * | 2013-12-05 | 2016-10-20 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| CN104151397A (zh) * | 2014-07-03 | 2014-11-19 | 北京大学 | 一类新型三硫杂二环有机砷化物及其合成方法和在抗肿瘤领域里的应用 |
| JP6413969B2 (ja) * | 2015-07-29 | 2018-10-31 | 住友金属鉱山株式会社 | 日射遮蔽体形成用分散液および当該分散液を用いた日射遮蔽体 |
| JPWO2019220961A1 (ja) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| CN113408945B (zh) * | 2021-07-15 | 2023-03-24 | 广西中烟工业有限责任公司 | 一种烤烟纯度的检测方法、装置、电子设备及存储介质 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US234972A (en) | 1880-11-30 | William ennis | ||
| US761900A (en) | 1904-03-05 | 1904-06-07 | Newton Jefferson Norman | Flux compound. |
| US2349729A (en) | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| AU751932B2 (en) | 1997-10-15 | 2002-08-29 | Polarx Biopharmaceuticals, Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| PT1964557E (pt) | 1997-11-10 | 2013-02-20 | Sloan Kettering Inst Cancer | Processo para a produção de formulações de trióxido de arsénio |
| CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| AU5391901A (en) | 2000-04-26 | 2001-11-07 | Univ Oregon Health Sciences | Administration of a thiol-based chemoprotectant compound |
| DE10132625A1 (de) | 2001-07-05 | 2003-01-23 | Oce Printing Systems Gmbh | Verfahren, Computerprogrammprodukt und Gerätesystem zum visuellen Überprüfen von Bilddaten |
| EP2420229A1 (en) * | 2002-01-07 | 2012-02-22 | Board Of Regents, University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| WO2007027344A2 (en) | 2005-07-29 | 2007-03-08 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| JP5202332B2 (ja) * | 2006-01-13 | 2013-06-05 | ザ テキサス エー アンド エム ユニバーシティ システム | がんの治療のための化合物および方法 |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| AU2008276451A1 (en) * | 2007-07-17 | 2009-01-22 | Zalicus Inc. | Treatments of B-cell proliferative disorders |
| CA2694987A1 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Combinations for the treatment of b-cell proliferative disorders |
| ES2392737T3 (es) * | 2007-11-02 | 2012-12-13 | Ziopharm Oncology, Inc. | Terapia combinada con compuestos arsenicales orgánicos |
| WO2009151569A2 (en) * | 2008-06-09 | 2009-12-17 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
-
2009
- 2009-08-14 DK DK09808635.8T patent/DK2321012T3/en active
- 2009-08-14 PT PT09808635T patent/PT2321012T/pt unknown
- 2009-08-14 SG SG10201810449XA patent/SG10201810449XA/en unknown
- 2009-08-14 BR BRPI0918407A patent/BRPI0918407A2/pt not_active Application Discontinuation
- 2009-08-14 KR KR1020187026317A patent/KR20180103194A/ko not_active Application Discontinuation
- 2009-08-14 RU RU2011110392/14A patent/RU2534606C2/ru active
- 2009-08-14 PT PT181748179T patent/PT3388111T/pt unknown
- 2009-08-14 CN CN2009801356542A patent/CN102149432A/zh active Pending
- 2009-08-14 JP JP2011523888A patent/JP5933896B2/ja active Active
- 2009-08-14 NZ NZ591181A patent/NZ591181A/xx not_active IP Right Cessation
- 2009-08-14 SG SG10201403869TA patent/SG10201403869TA/en unknown
- 2009-08-14 KR KR1020117006250A patent/KR20110058818A/ko active Search and Examination
- 2009-08-14 ES ES09808635T patent/ES2703740T3/es active Active
- 2009-08-14 SG SG10201810450QA patent/SG10201810450QA/en unknown
- 2009-08-14 KR KR1020177024240A patent/KR20170103023A/ko active Application Filing
- 2009-08-14 CA CA2734650A patent/CA2734650A1/en not_active Abandoned
- 2009-08-14 MX MX2011001800A patent/MX2011001800A/es not_active Application Discontinuation
- 2009-08-14 DK DK18174817.9T patent/DK3388111T3/da active
- 2009-08-14 US US13/059,176 patent/US20110269697A1/en not_active Abandoned
- 2009-08-14 EP EP09808635.8A patent/EP2321012B1/en active Active
- 2009-08-14 CN CN201410740427.5A patent/CN104800828A/zh active Pending
- 2009-08-14 EP EP18174817.9A patent/EP3388111B1/en active Active
- 2009-08-14 ES ES18174817T patent/ES2901426T3/es active Active
- 2009-08-14 WO PCT/US2009/053858 patent/WO2010021928A1/en active Application Filing
- 2009-08-14 AU AU2009282972A patent/AU2009282972A1/en not_active Abandoned
-
2011
- 2011-02-10 IL IL211153A patent/IL211153A0/en unknown
- 2011-02-15 ZA ZA2011/01216A patent/ZA201101216B/en unknown
- 2011-11-14 HK HK18113573.8A patent/HK1254607A1/zh unknown
-
2014
- 2014-05-26 JP JP2014108079A patent/JP5976036B2/ja active Active
- 2014-10-27 US US14/524,586 patent/US10842769B2/en active Active
-
2015
- 2015-03-30 JP JP2015068284A patent/JP2015120755A/ja not_active Withdrawn
-
2016
- 2016-01-07 HK HK16100117.0A patent/HK1212218A1/zh unknown
- 2016-09-29 JP JP2016191062A patent/JP6315841B2/ja active Active
-
2017
- 2017-12-19 JP JP2017242759A patent/JP2018039853A/ja active Pending
-
2020
- 2020-10-15 US US17/071,435 patent/US11324713B2/en active Active
- 2020-10-15 US US17/071,623 patent/US11324714B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201810450QA (en) | Organoarsenic compounds and methods for the treatment of cancer | |
| WO2008079339A3 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
| MX2009005649A (es) | Tratamiento para mieloma multiple. | |
| TW200744586A (en) | Therapeutic compounds | |
| WO2010093849A3 (en) | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | |
| MXPA05009694A (es) | Metodos para mejorar la calidad de la piel. | |
| BRPI0413746A (pt) | composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo | |
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| GEP20125643B (en) | Aurora kinase modulators and method of using same | |
| TW200732341A (en) | Chemical compounds | |
| WO2009026176A3 (en) | Antiinfective flavononol compounds and methods of use thereof | |
| EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
| BRPI0413740A (pt) | composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo | |
| HK1085675A1 (en) | Anticancer compounds | |
| NZ610378A (en) | Lipoyl compounds and their use for treating ischemic injury | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| TW200613292A (en) | Benzothiazolium compounds | |
| MX2010008226A (es) | Derivados de difluorobifenilamida para el tratamiento de hipertension ocular. | |
| UA107562C2 (uk) | Спосіб лікування псоріазу | |
| EA200701852A1 (ru) | Производные аминокислот | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| TW200600084A (en) | Anti-coronavirus compounds | |
| IL165259A0 (en) | Compounds useful in the treatment of anthraxa and inhibiting lethal factor |